GlucoTrack, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving GlucoTrack, Inc. now
Current reporting with the operating signal separated from the noise.
TechStock²
GlucoTrack, Inc. (NASDAQ:GCTK) surges 95% after LT-100 news, market eyes dilution impact
The story matters when it changes GlucoTrack, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest GCTK filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
10-QQuarterly financial reportFiled 2026-05-14 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-13 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-30 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-30 · Period 2026-07-29SEC ↗8-K/AMaterial company eventFiled 2026-07-29 · Period 2026-07-22SEC ↗8-KMaterial company eventFiled 2026-07-27 · Period 2026-07-22SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-07-17 · Period 2026-07-17SEC ↗PRE 14AOfficial SEC filingFiled 2026-07-31 · Period 2026-07-31SEC ↗
GlucoTrack, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →